ArticleCirculation reports2025
Comparison of Short-Term Clinical Outcomes Between Intravascular Lithotripsy and Rotational Atherectomy for Calcified Coronary Stenosis in Patients With Acute Coronary Syndrome.
Article in Circulation reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics: update 2026.Cardiovascular intervention and therapeutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The optimal revascularization strategy for calcified lesions in patients with acute coronary syndrome (ACS) remains unclear. This study aimed to compare the short-term outcomes of intravascular lithotripsy (IVL) and rotational atherectomy (RA) for patients with ACS resulting from calcified lesions. Methods and Results: Among 3,556 consecutive patients with ACS who underwent primary percutaneous coronary intervention (PCI) between 2016 and 2024, we retrospectively analyzed 52 patients who received drug-eluting stents with either IVL (n=24) or RA (n=28) for calcified lesions. The primary outcome was the incidence of major adverse cardiovascular events (MACE). In addition, we evaluated slow-flow or no-reflow phenomena incidence during PCI and the procedural success rate. Compared with patients with RA, those with IVL had a smaller preprocedural minimum lumen diameter and a larger preprocedural reference vessel diameter. Primary outcomes and procedural success rates were comparable between both groups. However, the slow-flow or no-reflow incidence was significantly lower in the IVL group than in the RA group. After adjusting for confounders, IVL was independently associated with a lower slow-flow or no-reflow incidence. Conclusions: In patients with ACS due to calcified lesions, there was no significant difference in 30-day MACE incidence between both groups. However, slow-flow incidence was lower in the IVL group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.